Bacillus cereus G9241, the causative agent of anthrax-like disease, harbors virulence plasmids encoding anthrax toxins as well as hyaluronic acid (HA) and B. cereus exopolysaccharide (BPS) capsules. B. cereus G9241 also harbors S-layer genes, including homologs of Bacillus anthracis surface array protein (Sap), extractable antigen 1 (EA1), and the S-layer-associated proteins (BSLs). In B. anthracis, S-layer proteins and BSLs attach via their S-layer homology domains (SLH) to the secondary cell wall polysaccharide (SCWP) in a manner requiring csaB, a predicted ketalpyruvate transferase. Here we used a genetic approach to analyze B. cereus G9241 S-layer assembly and function. Variants lacking the csaB gene synthesized SCWP but failed to retain Sap, EA1, and BSLs in the bacterial envelope. The B. cereus G9241 csaB mutant assembled capsular polysaccharides but displayed an increase in chain length relative to the wild-type strain. This phenotype is likely due to its inability to deposit BslO murein hydrolase at divisional septa. During growth under capsule-inducing conditions, B. cereus G9241 assembled BSLs (BslA and BslO) and the Sap S-layer protein, but not EA1, in the envelope. Finally, csaB-mediated assembly of S-layer proteins and BSLs in B. cereus G9241 contributes to the pathogenesis of anthrax-like disease in mice.
B. cereus strains that are pathogenic to humans and animals (including B. anthracis) but are otherwise absent from environmental B. cereus isolates lacking the capacity to cause disease (28) . Here we asked whether S-layer formation and HA/BPS capsule synthesis occur in B. cereus G9241 as independent, compatible events and whether assembly of the S-layer contributes to the pathogenesis of anthrax-like disease.
MATERIALS AND METHODS
Bacterial growth and capsule production. B. cereus G9241 and its variants were cultured in brain heart infusion (BHI) broth. Escherichia coli was grown in Luria-Bertani broth. When necessary, growth media were supplemented with spectinomycin (200 g ml Ϫ1 ) or kanamycin (50 g ml Ϫ1 ) to maintain plasmid selection. B. cereus strains were sporulated during growth in modified G medium (29) . Spore suspensions were germinated by inoculation into BHI and grown at 30°C. For capsule production, spores of B. cereus G9241 or its variants were inoculated into 50% (vol/vol) heat-inactivated fetal bovine serum (FBS) containing BHI. Bacterial growth, genetic manipulation, and animal experiments involving B. cereus G9241 and its variants were carried out with approved protocols in biological safety level 3 containment laboratories under supervision of the institutional biosafety committee of the University of Chicago. Construction of plasmids and Bacillus cereus G9241 strains. B. cereus G9241 csaB mutants were constructed by allelic replacement of coding sequences with an omega element conferring spectinomycin resistance (⍀-Sp), using the temperature-sensitive plasmid pLM4 (30) . Two fragments of approximately 1-kb DNA sequences flanking the csaB coding region (BCE_G9241_0889 and NZ_AAEK01000002.1) were amplified by PCR using two primers pairs, csaB-UPF (TTTCCCGGGGATACTGCAG GTTTCGATTCCA)/csaB-UPR (TTTGGTACCCTTAATCTCCTCCAA CATTTCGC) and csaB-DNF (TTTGGATCCGAGGACATCCTCTTTTT TATTTTTTG)/csaB-UPR (TTTGAATTCGCCCATGAATCTTGAGCA TC). PCR fragments were ligated into the pLM4 XmaI and EcoRI restriction sites. In this construct, a KpnI restriction site was inserted between the two fragments, where the blunted ⍀-Sp cassette from pJRS312 plasmid (31) was inserted to generate pYT19. pYT19 was isolated from E. coli K1077 (dcm/dam) (32) prior to electroporation into B. cereus. Cultures of B. cereus G9241 harboring pYT19 were diluted 1:100, plated on BHI agar (50 g ml Ϫ1 kanamycin) and incubated at 43°C overnight (restrictive temperature). Single colonies were inoculated into LB broth without antibiotics and cultures passaged every 12 h at 30°C to ensure loss of plasmid. DNA from kanamycin-sensitive colonies was isolated and analyzed by PCR for the presence or absence of mutant alleles. Nucleic acid sequences of wild-type and mutant alleles were verified by DNA sequencing. Plasmid pcsaB was derived from pLM4 and used for complementation. The csaB gene as well as its upstream flanking region including the native promoter was amplified using the primers csaBF (TTTCCCG GGATGAGTCCATAAATGAGTCCATAAATG) and csaBR (TTTGGTA CCTTGATATATTTCCTCCTTAGGAATGTAA). Mutations were transduced into B. cereus ⌬hasACB, ⌬bpsX-H, and ⌬hasACB ⌬bpsAB mutants (25) to generate double or triple mutants (33) . Briefly, bacteriophage CP-51 was used to infect the B. cereus G9241 csaB::⍀-Sp strain and generate a lysate (34) . Filtered CP-51 phages from such lysates were used to transduce the csaB::⍀-Sp allele into B. cereus capsular mutants. Spectinomycin-resistant transductants were screened by PCR and mutants were confirmed by DNA sequencing.
Immunoblotting. B. cereus overnight cultures were diluted 1:100 into fresh BHI and grown to an A 600 of 2.5. Where indicated, spores were inoculated into 50% FBS to induce B. cereus capsule production. Onemilliliter aliquots were removed from the culture and centrifuged at 13,000 ϫg for 10 min to separate supernatant (culture medium) and sediment (vegetative forms). Proteins in the supernatant were precipitated by addition of trichloroacetic acid (TCA; final concentration, 10%). Vegetative bacilli were washed in PBS and proteins precipitated with 10% TCA. All protein precipitates were sedimented by centrifugation at 13,000 ϫ g for 10 min, washed with ice-cold acetone, dried, and suspended in sample buffer. Samples were heated at 95°C for 10 min and subjected to electrophoresis on SDS-PAGE. Proteins were electrotransferred to polyvinylidene difluoride (PVDF) membrane and probed with specific polyclonal rabbit IgG antibodies (anti-Sap, anti-EA1, anti-BslA, anti-BslO, or anti-L6) as well as anti-rabbit IgG secondary antibody conjugated to horseradish peroxidase, followed by chemiluminescence detection.
Scanning electron microscopy. Bacilli were washed in H 2 O, fixed for 30 min in 2% glutaraldehyde-PBS at room temperature, and then postfixed for 30 min on freshly prepared poly-L-lysine coated glass coverslips. Samples were washed twice with PBS and serially dehydrated by consecutive incubations in 25% and 50% ethanol-PBS (vol/vol), 75% and 90% ethanol-H 2 O, and 100% ethanol (twice), followed by 50% ethanol-hexamethyldisilazane (HDMS) and finally 100% HDMS. After overnight evaporation of HDMS at room temperature, samples were incubated for 3 h at 37°C, mounted onto specimen mounts (Ted Pella, Inc., Redding, CA), and coated with 80% Pt-20% Pd to 8 nm using a Cressington 208HR sputter coater at 20 mA prior to examination in a Fei Nova NanoSEM 200 scanning electron microscope (FEI Co., Hillsboro, OR). The microscope was operated with an acceleration voltage of 5 kV, and samples were viewed at a distance of 5 mm.
Purification of Bacillus anthracis SCWP. B. anthracis Sterne (34F2)
was grown overnight at 37°C on BHI agar, and bacteria were scraped off the plates, suspended and washed in water. Bacilli were boiled for 30 min in 4% SDS, washed and suspended in water, and then broken in a bead beater instrument with 0.1 mm glass beads. Murein sacculi were sedimented by centrifugation and suspended in 100 mM Tris-HCl (pH 7.5). Samples were incubated for 4 h at 37°C with 10 g/ml DNase and 10 g/ml RNase supplemented with 20 mM MgSO 4 and then incubated for 16 h at 37°C with 10 M trypsin supplemented with 10 mM CaCl 2 . Enzymes were inactivated by boiling for 30 min in 1% SDS. The detergent was removed by repeated centrifugation and water-washing steps. Murein sacculi were washed with successive steps in water, 100 mM Tris-HCl (pH 8.0), water, 100 mM EDTA (pH 8.0), water, and acetone and finally twice with water. Murein sacculi were suspended in a small volume (5 to 7 ml) of water, and 25 ml of 48% hydrofluoric acid was added for overnight incubation on ice. The SCWP-containing supernatant was added to icecold ethanol at a ratio of 1:5. The SCWP precipitate was sedimented by centrifugation and washed extensively with ice-cold ethanol.
SCWP-specific antiserum. Purified SCWP was dialyzed against water overnight and lyophilized. One mg of dried polysaccharide was dissolved in 90 l of 0.15 M HEPES buffer (pH 7.4). Subsequently, 90 l of 45 mg/ml of 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) in acetonitrile and 120 l of aqueous 0.3 M triethylamine as well as 4 mg bovine serum albumin (BSA) dissolved in 350 l 0.01 M PBS (pH 7.4) were added (26) . The solution was stirred at 4°C for 18 h, and carbohydrate conjugation to BSA was quenched by adding 120 l of 0.5 M ethanolamine in 0.75 M HEPES buffer (pH 7.4). Nonconjugated sugars were removed by filtration. The conjugate was emulsified by mixing 500 g SCWP-BSA conjugate in 500 l complete Freund's adjuvant (Difco). The samples were injected subcutaneously into female New Zealand White rabbits. Antibody production was stimulated at 21-day intervals with two booster injections of SCWP-BSA antigen emulsified in incomplete Freund's adjuvant.
Light and fluorescence microscopy. Digital micrographs of bacterial samples fixed with PBS buffered 4% formalin were captured with a CCD camera on an Olympus IX81 microscope with 100ϫ, 40ϫ, 20ϫ or 4ϫ objectives. Length data were measured directly from micrographs using ImageJ software. To visualize capsules, india ink was added to samples prior to imaging. To probe for Sap, BslO, BslA, as well as SCWP, immunofluorescence microscopy experiments were performed. Briefly, fixed bacilli were sedimented by centrifugation at 10,000 ϫ g, washed in PBS and blocked with 3% bovine serum albumin (wt/vol in PBS) or 3% horse serum (vol/vol in PBS). Specific rabbit antisera were diluted 1:1,000 into PBS and incubated with the cells for 1 h followed by three washes in PBS and labeling with Alexa-Fluor 594 conjugated goat anti-rabbit IgG (Fisher) prior to microscopy.
Animal challenge. Protocols for animal experiments were reviewed, approved and supervised by the Institutional Animal Care and Use Committee at the University of Chicago (IACUC). All infections were carried out in animal biological safety level 3 containment laboratories at the Howard Taylor Ricketts Laboratory. Female C57BL/6 mice (Jackson Laboratory) were challenged by intraperitoneal injection of B. cereus spores as described previously (25) . Moribund animals were euthanized and subjected to necropsy, and their spleens, livers, kidneys, and lungs were removed. Organs were immediately fixed by submersion in 10% neutral buffered formalin and embedded in paraffin. Samples were submitted to the University of Chicago Animal Pathology Core for serial 4-m thin sectioning and stained with hematoxylin-eosin. Tissue samples were viewed by light microscopy. Organ samples isolated during necropsy were also homogenized in phosphate-buffered saline, serially diluted, and plated on tryptic soy agar (TSA) to enumerate bacterial loads (in CFU). Alternatively, samples were fixed with neutral buffered formalin and stained with india ink to visualize the capsules of bacilli.
Animals were managed by the University of Chicago Animal Resource Center. Animals judged to be moribund were euthanized using cervical dislocation followed by midline incision of the thorax. Acquired data were processed using GraphPad PRISM 5.0 software to generate graphs for statistical analyses. Data on bacterial load were analyzed with the unpaired two-tailed Student's t test. Comparisons of animal survival between cohorts challenged with different strains were examined with the log-rank test.
RESULTS

S-layer genes of Bacillus cereus G9241.
The BLAST search algorithm was used to identify the S-layer genes of B. cereus G9241, using nucleotide sequences of B. anthracis Sterne genes as queries (35, 36) . The csaB-sap-eag genes of B. cereus G9241 are 98%, 72%, and 89% identical to the corresponding genes of B. anthracis (Fig.  1B) (9, 24) . Queries of the B. cereus G9241 genome with the SLH Pfam domain (PF00395) identified 25 genes whose predicted products contain N-terminal signal peptides as well as SLH domains, i.e., the two S-layer proteins and 23 BSLs (Fig. 1) . The B. cereus G9241 genome lacks the bslG, bslK, and amiA genes of B. anthracis yet harbors three unique bsl genes not found in the genomes of other B. anthracis isolates (bclV, bslW, and bslX) (Fig. 1) .
Isolation and characterization of B. cereus G9241 csaB mutants. The omega-spectinomycin cassette (⍀-Sp) and DNA sequences flanking csaB (BCE_G9241_0889, GI:47558208) were used to generate a csaB mutant of B. cereus G9241 harboring the csaB::⍀-Sp allele. When propagated on agar, the csaB mutant formed small colonies that lacked the ground-glass-like appearance of wild-type colonies (12) (Fig. 2A) . Scanning electron microscopy experiments revealed B. cereus G9241 vegetative bacilli as short chains of incompletely separated cells, typically 2 to 8 vegetative bacilli in length (Fig. 2B) . In contrast, the chain length of the csaB mutant was exaggerated; on some electron microscopy images chains appeared to be Ͼ50 vegetative cells in length. Transformation of the csaB mutant with pLM4 (empty plasmid vector) did not affect the chain length phenotype of vegetative forms. On the other hand, expression of wild-type csaB from a plasmid (pcsaB) restored the chain length to wild-type levels (Fig.  2B ). Growth and chain length of vegetative bacilli were quantified following germination of wild-type and mutant spores in fresh media. The csaB mutant with or without the complementing plasmid (pcsaB) grew at the same rate as wild-type bacilli (Fig. 2C) . Culture aliquots were removed at timed intervals and observed by light microscopy, and average chain lengths of bacilli were quantified. Two hours after inoculation of spores into fresh nutrient broth, the average chain length of the csaB mutant (12.69 Ϯ 0.3391 m; n ϭ 109) was greater than that of wild-type bacilli (9.889 Ϯ 0.2099 m; n ϭ 109) ( Fig. 2D ; wild-type versus csaB mutant, P Ͻ 0.0001). A similar result was observed at the 3-h interval (wildtype, 36.00 Ϯ 1.693 m, versus csaB mutant, 41.41 Ϯ 1.880; P ϭ 0.0336). At later intervals (4, 5, 6 , and 7 h), the chain lengths of the wild-type bacilli gradually decreased, whereas those of the csaB mutant did not (Fig. 2D) . The chain length phenotype of the csaB mutant is due to the csaB::⍀-Sp mutation, as plasmid-encoded wild-type csaB (pcsaB) reduced the chain length of the mutant to wild-type levels (Fig. 2D) .
The csaB gene is required for S-layer assembly in the envelope of B. cereus G9241. We sought to characterize the assembly of S-layer (Sap and EA1) and S-layer-associated (BslO) proteins in the envelope of wild-type and csaB mutant B. cereus G9241. BslO is a peptidoglycan hydrolase, which localizes to the septal region of B. anthracis vegetative chains (12, 37) . B. cereus G9241 cultures were centrifuged, and the extracellular medium was separated with the supernatant (S) from the bacterial sediment (pellet [P]). Proteins in both fractions were analyzed by immunoblotting. B. cereus G9241 retained Sap, EA1, and BslO in its envelope (Fig. 3A) . In contrast, the csaB mutant released all of these proteins into the extracellular medium (Fig. 3A) . As a control, ribosomal protein L6 was found in the bacterial sediment of all strains tested (Fig. 3A) . The ability of the csaB mutant to retain Sap, EA1, and BslO in the bacterial envelope was restored when the mutant was transformed with plasmid pcsaB but not with the vector control (pLM4) (Fig. 3A) .
Immunofluorescence microscopy of vegetative chains was used to detect Sap, BslO, and the secondary cell wall polysaccharide (SCWP) in the bacterial envelope. To visualize the septal region, images of bacilli were captured by phase-contrast and fluorescence microscopy after staining with BODIPY-vancomycin, which reveals newly synthesized peptidoglycan in the septa of dividing bacilli (30, 38) . Sap and BslO were detected mostly at the septal regions of B. cereus G9241 vegetative chains but were also distributed throughout the envelope (Fig. 3B) . A similar distribution was observed for the SCWP (Fig. 3B) . As expected, immuno- fluorescence microscopy failed to detect Sap in the envelope of csaB mutant bacilli (see Fig. S1 in the supplemental material). In contrast, distribution and abundance of the SCWP in the bacterial envelope were not affected by the csaB mutation (Fig. 3C) .
Capsule formation in wild-type and csaB mutant B. cereus G9241. The production of HA and BPS capsule is induced when B. cereus G9241 is grown in medium containing blood products, for example BHI supplemented with 50% fetal bovine serum (BHI-FBS) (25) . Capsule production in B. cereus G9241 was detected by india ink exclusion staining and light microscopy (Fig. 4A) . Disruption of the csaB gene did not alter capsule formation (Fig. 4A,  top right) . Similarly, transformation of bacilli with pLM4 or pcsaB did not affect the production of capsular polysaccharides (Fig. 4A,  bottom) . To examine whether HA and BPS were expressed in wild-type and csaB mutant strains, we introduced the csaB::⍀-Sp allele into bacilli carrying deletions in the genes required for HA (⌬hasACB) or BPS (⌬bpsX-H) capsule formation. Spores of the mutant strains were inoculated into BHI-FBS, and replicating vegetative forms were analyzed by microscopy. As previously reported, the ⌬bpsX-H and ⌬hasACB strains formed capsular polysaccharides that were somewhat thinner than that of the wildtype, whereas the ⌬hasACB ⌬bpsAB mutant was unable to produce any capsule (Fig. 4B) (25) . Introduction of the csaB:: ⍀-Sp allele into the ⌬bpsX-H, ⌬hasACB, or ⌬hasACB ⌬bpsAB mutant strains did not affect capsule production. These data suggest that the S-layer proteins Sap and EA1 as well as the S-layerassociated proteins are not required for HA and BPS capsule production in B. cereus G9241.
S-layer production during B. cereus G9241 growth. We sought to determine whether B. cereus G9241 cultures induced for capsule production also express S-layer and S-layer-associated proteins. During exponential growth (A 600 ϭ 1) either with (BHI-FBS) or without (BHI) fetal bovine serum, bacillus gene expression was analyzed by immunoblotting of the corresponding protein product (Fig. 5A) . During exponential growth in BHI-FBS, B. cereus G9241 synthesized the S-layer protein Sap but not the EA1 polypeptide (Fig. 5A) . Further, BslO and BslA, the pBCXO1 (pXO1)-encoded homolog of the S-layer-associated protein and adhesin of B. anthracis (9) , were readily detected (Fig. 5A) . When sampled during exponential growth in BHI without FBS, B. cereus
FIG 3 The B. cereus G9241 csaB mutant cannot assemble S-layer proteins and S-layer-associated proteins into the bacterial envelope. (A) B. cereus G9241
wild-type and csaB mutant were grown to exponential phase in BHI broth. Bacilli harbored no plasmid (Ø), the pLM4 vector, or the complementing plasmid pcsaB. Cultures were centrifuged to sediment vegetative bacilli (pellet [P]) and separate them from the extracellular medium (supernatant [S]). Proteins in both fractions were precipitated with TCA and analyzed by immunoblotting with rabbit antisera raised against purified recombinant Sap (␣Sap), EA1 (␣EA1), BslO (␣BslO), and ribosomal protein L6 (␣L6). The migratory positions of molecular mass markers on SDS-PAGE are indicated. (B) Immunofluorescence and phase-contrast microscopy images of wild-type B. cereus G9241 grown to exponential phase in BHI. Bacilli were stained with antisera specific for Sap, BslO, or SCWP and with secondary antibody conjugated to Alexa-Fluor 594 (red). To reveal the cell wall septa between adjacent bacilli, chains were stained with BODIPY-vancomycin (green), which binds the peptidoglycan precursor lipid II. (C) Immunofluorescence and phase-contrast microscopy images of csaB mutant B. cereus G9241 grown to exponential phase in BHI. Bacilli were stained with antisera specific for the SCWP (red) or with BODIPY-vancomycin (green). Data are representative of three independent experimental determinations.
G9241 produced neither capsular polysaccharides (data not shown) nor BslA (Fig. 5A) . Similar to B. anthracis variants lacking PDGA capsule (39), exponential-phase B. cereus G9241 cultures with FBS induction expressed the S-layer protein Sap but not EA1 (Fig. 5A) . During late exponential/stationary phase in BHI-FBS or BHI cultures (A 600 ϭ 4), B. cereus G9241 synthesized both Sap and EA1 but not BslA (Fig. 5B) . The murein hydrolase BslO was detected in exponential-and stationary-phase cultures (Fig. 5) . As a control, the peptidylprolyl isomerase PrsA was found in bacilli that had been grown in the presence or absence of serum (Fig. 5) . During all growth stages under both capsule-inducing and noninducing conditions, the B. cereus G9241 csaB variant failed to retain S-layer and S-layer-associated proteins in the bacterial envelope (Fig. 5) . This defect was complemented by pcsaB (Fig. 5) . Deletion of capsule genes did not affect the expression or retention of S-layer and S-layer-associated proteins, as both wild-type and ⌬hasACB ⌬bpsAB mutant bacilli harbored similar amounts of Slayer and S-layer-associated proteins (Fig. 5) .
Surface display of BslA by encapsulated B. cereus G9241. As BslA, but not Sap or EA1, is expressed in B. cereus G9241 during capsule production, we examined the distribution and surface display of BslA in encapsulated bacilli (Fig. 6) . When grown in BHI-FBS and stained with india ink, B. cereus G9241 vegetative forms were found to be fully encapsulated. The BslA adhesin was detected by immunofluorescence microscopy and was found to be distributed throughout the bacterial envelope (Fig. 6) . Deletion of the csaB gene abolished BslA display on the surface of B. cereus (Fig. 6A) . In contrast, deletion of HA (⌬hasACB), BPS (⌬bpsX-H), or HA and BPS (⌬hasACB ⌬bpsAB) capsule genes did not affect the display of BslA on the surface of B. cereus (Fig. 6A) .
The S-layer of B. cereus G9241 contributes to the pathogenesis of anthrax-like disease. Cohorts of C57BL/6 mice (n ϭ 10) were injected into the peritoneal cavity with 1 ϫ 10 5 spores derived from either wild-type G9241 (30 mean lethal dose equivalents) as well as its ⌬hasACB ⌬bpsAB or csaB mutant vegetative forms (25) . All animals challenged with wild-type spores suc- cereus G9241 wild-type and csaB mutant were grown at 30°C for 5 h in BHI broth with 50% fetal bovine serum (BHI-FBS). Mutant bacilli harbored no plasmid, the pLM4 vector, or the complementing plasmid pcsaB. Capsule formation was detected by microscopy of india ink-stained samples. Data are representative of three independent experimental determinations. (B) B. cereus G9241 mutants lacking capsular polysaccharide operons responsible for BPS (⌬bpsX-H), hyaluronic acid (HA; ⌬hasACB), or BPS and HA production (⌬hasACB ⌬bpsAB) were transduced with the csaB::⍀-Sp allele. Capsule formation was detected by microscopy of india ink-stained samples. Data are representative of three independent experimental determinations.
FIG 5 Expression of B. cereus G9241 S-layer proteins and S-layer-associated
proteins under capsule-inducing conditions. B. cereus G9241 was grown under capsule-inducing (BHI-FBS) or noninducing (BHI) conditions to (A) exponential (A 600 ϭ 1) or (B) late exponential/stationary phase (A 600 ϭ 4). Cultures were centrifuged to sediment vegetative bacilli, and the extracellular medium was removed. Proteins were precipitated with TCA and analyzed by immunoblotting with rabbit antisera raised against purified recombinant Sap (␣Sap), EA1 (␣EA1), BslA (␣BslA), BslO (␣BslO), and membrane protein PrsA (␣PrsA). The abundance of S-layer proteins and S-layer-associated proteins in the envelopes of B. cereus G9241 wild-type, csaB, csaB(pcsaB), and ⌬hasACB ⌬bpsAB strains was compared. Data are representative of three independent experimental determinations.
cumbed to infection within 40 to 80 h (median time of survival, 48.5 h) (Fig. 7A ). Animals challenged with the csaB mutant displayed a delayed time to death (median time of survival, 76.5 h), even though most animals succumbed to infection within 65 to 120 h. When these data were analyzed with the log-rank test, a significant difference in survival between wild-type and csaB mutant challenge groups was seen (P ϭ 0.0002).
All animals that were infected with spores of the nonencapsulated variant (⌬hasACB ⌬bpsAB mutant) survived the challenge, similar to experiments detailed in an earlier report (25) . Moribund animals were euthanized and necropsied, and spleen as well as lung tissue was stained with hematoxylin-eosin and examined for the histopathology features of anthrax-like disease. The spleens of animals that had been challenged with wild-type B. cereus G9241 spores displayed the characteristic displacement of red pulp tissue with massive numbers of vegetative bacilli (Fig. 7B) . Large numbers of leukocytes, irregularly scattered throughout the bacterial population, were also associated with these lesions (Fig. 7B) . India ink staining of spleen tissue revealed the encapsulated vegetative forms of B. cereus G9241 (Fig. 7C) . As reported earlier (25) , lung tissue from animals infected with B. cereus G9241 exhibited areas of focal inflammation and bacterial replication suggestive of a secondary pneumonia. Microcolonies of bacilli were observed in capillaries and occasionally in alveolar spaces but without significant immune cell infiltrates of the parenchyma (Fig. 7B) . Mice that had been infected with the csaB mutant spores also displayed the displacement of the red pulp in the spleen with vegetative bacilli (Fig. 7B) . As revealed by india ink staining, csaB mutant vegetative forms were fully encapsulated (Fig. 7C) . In contrast to animals infected with wild-type spores, mice challenged with the csaB mutant developed remarkably few features of B. cereus G9241 lung disease (Fig. 7B). 
DISCUSSION
B. anthracis, the causative agent of anthrax disease (2), elaborates PDGA capsule (3), thereby endowing vegetative forms with the ability to escape phagocytic clearance in tissues of infected hosts (5) . B. anthracis also elaborates an S-layer via the assembly of two secreted products, Sap and EA1, which are arrayed into a twodimensional paracrystalline lattice enveloping vegetative cells. In addition to Sap and EA1, the S-layer accommodates S-layer-associated proteins that have a wide spectrum of functions, including cell separation (BslO) (12) , bacterial adhesion to host tissues (BslA) (9) and nutrient uptake (BslK) (11) . Electron microscopy studies revealed the envelope structure of B. anthracis, in which linear PDGA strands traverse the bacterial peptidoglycan and Slayer (15) . Retention of secreted S-layer proteins in the bacterial envelope requires the synthesis of the SCWP (14) , which is immobilized via murein linkage units to the cell wall (6) . Modification of the terminal ␤-ManNAc residue of the SCWP with ketalpyruvate in a reaction that is presumably catalyzed by the csaB gene product is a prerequisite for S-layer assembly (6, 40) . The three-pronged spindle structure derived from the three SLH domains in S-layer and S-layer-associated proteins binds to pyruvylated SCWP, thereby enabling the assembly of the S-layer in the envelope of B. anthracis (13) . Analysis of the contribution of the S-layer to anthrax disease, for example through the analysis of B. anthracis csaB mutants in animal challenge experiments, has not yet been carried out. Nevertheless, as the pXO1-encoded BslA adhesin of B. anthracis contributes to pathogenesis in guinea pigs (10) , it seems plausible that bacterial S-layer assembly may also be an important feature of anthrax.
B. cereus G9241 is the causative agent of respiratory anthraxlike disease in humans, which is most frequently observed in welders (23) . The genome sequence of B. cereus G9241 revealed its close homology to other B. cereus strains isolated from human cases with fatal pneumonia as well as the presence of three plasmids, designated pBCXO1, pBC218, and pBClin29 (24) . When tested in mice with a peritoneal challenge model, B. cereus G9241 causes anthrax-like disease in a manner requiring genes for protective antigen (pagA, located on pBCXO1), BPS (bpsX-H on pBC218), and HA polysaccharides (hasACB on pBCXO1). Further, B. cereus G9241 causes respiratory anthrax-like disease in rabbits (41) . Of note, B. cereus G9241 does not harbor the capBC-DAE genes, which are present on B. anthracis pXO2 (24, 42) . B. anthracis lacks the bpsX-H genes of B. cereus G9241 and harbors a frameshift mutation in the hasA gene on pXO1, which abolishes the synthesis of HA capsule (25) . Thus, the structure of capsules elaborated by B. anthracis and B. cereus G9241 is fundamentally different, raising the possibility that assembly and function of Slayer and S-layer-associated proteins may also differ between these two closely related species.
We show here that B. cereus G9241 elaborates two S-layer proteins, Sap and EA1, which are conserved relative to the S-layer proteins of B. anthracis but not identical to them (Fig. 1B) . The S-layer and S-layer-associated proteins (BslA and BslO) of B. cereus G9241 are retained in the bacterial envelope in a manner requiring csaB, a gene whose sequence is virtually identical to that (n ϭ 10) of C57BL/6 mice following intraperitoneal inoculation of (1 ϫ 10 5 ) spores derived from B. cereus G9241 wild-type as well as ⌬hasACB ⌬bpsAB and csaB mutant strains. When analyzed with the log-rank test, the survival of animals infected with the csaB mutant is significantly increased compared to animals infected with the wild-type strain (P ϭ 0.0002). The ⌬hasACB ⌬bpsAB mutant was avirulent in this model (wild-type versus ⌬hasACB ⌬bpsAB, P Ͻ 0.0001). Data are representative of two independent experimental determinations. (B) Spleen tissue homogenates from animals infected with wild-type B. cereus G9241 or the csaB mutant were stained with india ink and viewed by microscopy. Images are representative of vegetative forms identified in spleen tissues from five different animals analyzed for each group. (C) Naïve (uninfected) or moribund animals (infected with either wild-type B. cereus G9241 or its csaB mutant) were euthanized and necropsied. Lung and spleen tissues were fixed, thin sectioned, stained with hematoxylin-eosin, and analyzed for histopathology features via light microscopy at magnifications of ϫ40 (left) and ϫ400 (right). Images are representative of histopathology found in each of five animals per cohort. See the text for details.
of B. anthracis. Together with the observation that B. cereus G9241 elaborates SCWP with a structure similar to that of B. anthracis (27) , we presume that the overall mechanism of envelope assembly from S-layer and S-layer-associated proteins is likely conserved between the two species. Furthermore, B. cereus G9241 capsule production is induced via CO 2 (bicarbonate) and serum signals, as occurs for B. anthracis (43) . Under such conditions, the B. cereus G9241 S-layer protein Sap is synthesized, while EA1 cannot be detected during exponential growth. Further, the S-layerassociated proteins BslA and BslO are both produced and assembled into the bacterial envelope. Thus, similar to B. anthracis, capsule (BPS as well as HA) and S-layer proteins are compatible structures in B. cereus G9241 that likely require a coordinated assembly process (15) .
The finding that B. cereus G9241 csaB mutants cannot retain S-layer proteins and display a concomitant decrease in virulence suggests that S-layer assembly is important for the pathogenesis of anthrax-like disease. In addition to the observed delay in time to death, we noted altered histopathological features in lung but not in spleen tissues infected by the csaB mutant. These observations are in agreement with the conjecture that S-layers and S-layerassociated proteins have many different functions during infection. One of these functions is the control of the chain length of vegetative forms (12, 37, 44) , which represents a mechanism for bacterial escape from opsonophagocytic killing. Simply put, if bacillus chain length exceeds the size of macrophages or granulocytes, bacteria cannot be engulfed (45) . During infection of experimental animals, B. anthracis elaborates vegetative forms with and without PDGA capsule (5). It is conceivable that a similar phenomenon exists for B. cereus G9241, which could help explain the need for S-layer and S-layer-associated protein assembly controlling chain length during infection.
